EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Remarkable Clinical Improvement after Folinic Acid Supplementation in Cerebral Folate Transport Deficiency and Epileptic Encephalopathy: A Case Report

Çağatay Günay, Hande Gazeteci Tekin

Molecular Syndromology · 18.06.2026 · 1-11

DOI: 10.1159/000553193 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Syndromology, online erschienen am 18.06.2026. Verfasst von Çağatay Günay und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Siirt Training and Research Hospital, Siirt, Turkey. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Folate plays a critical role in central nervous system development, particularly in myelin synthesis and neurotransmitter metabolism. Cerebral folate transport deficiency (CFTD), most often caused by biallelic pathogenic variants in the FOLR1 gene, results in markedly reduced cerebrospinal fluid (CSF) folate levels despite normal systemic folate status. Affected individuals typically present with developmental regression, seizures, and movement disorders. Early diagnosis and folinic acid supplementation have been shown to reverse neurological symptoms, emphasizing the importance of prompt recognition. Case Presentation: We describe a 6-year-old girl born to consanguineous parents who initially presented with autism spectrum disorder and drug-resistant epilepsy. Her seizures included myoclonic-atonic, generalized myoclonic, and focal seizures, with subsequent gait instability and ataxia. Neuroimaging revealed diffuse cerebral atrophy and white matter signal abnormalities. Subsequent genetic testing identified a homozygous FOLR1 missense likely pathogenic variant (c.544T>A; p.Phe182Ile). The diagnosis was further confirmed by CSF analysis showing severe folate deficiency (5-MTHF: 4 nmol/L). Following initiation of oral folinic acid (4 mg/kg/day), seizures resolved completely, and substantial improvements were observed in ambulation, speech, and social interaction.

Conclusion

This case illustrates that folinic acid supplementation can lead to remarkable neurological recovery, even with substantial diagnostic delay. FOLR1-related CFTD should be considered in children with refractory epilepsy and developmental regression.

Schlagwörter

Stichwörter der Autor:innen

Case reportCerebral folate deficiencyDrug-resistant epilepsyFOLR1 geneFolinic acid

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Siirt Training and Research Hospital, Siirt, Turkey.
  • Department of Pediatric Neurology, İzmir Bakırçay University Çiğli Training and Research Hospital, İzmir, Turkey.

Zitieren

APA

Günay, Ç., & Gazeteci Tekin, H. G. (2026). Remarkable Clinical Improvement after Folinic Acid Supplementation in Cerebral Folate Transport Deficiency and Epileptic Encephalopathy: A Case Report. Molecular Syndromology, 1-11. https://doi.org/10.1159/000553193

Vancouver

Günay Ç, Gazeteci Tekin HG. Remarkable Clinical Improvement after Folinic Acid Supplementation in Cerebral Folate Transport Deficiency and Epileptic Encephalopathy: A Case Report. Molecular Syndromology. 2026:1-11. doi:10.1159/000553193

BibTeX
@article{Gnay2026,
  author = {Günay, Çağatay and Gazeteci Tekin, Hande},
  title = {Remarkable Clinical Improvement after Folinic Acid Supplementation in Cerebral Folate Transport Deficiency and Epileptic Encephalopathy: A Case Report},
  journal = {Molecular Syndromology},
  year = {2026},
  pages = {1--11},
  doi = {10.1159/000553193}
}
Kostenlos starten →